Underhill Investment Management Lowers stake in Dolby Laboratories (DLB)

Dolby Laboratories (DLB) : Underhill Investment Management reduced its stake in Dolby Laboratories by 1.45% during the most recent quarter end. The investment management company now holds a total of 88,350 shares of Dolby Laboratories which is valued at $4,413,966 after selling 1,300 shares in Dolby Laboratories , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Dolby Laboratories makes up approximately 2.29% of Underhill Investment Management’s portfolio.

Other Hedge Funds, Including , American Century Companies Inc boosted its stake in DLB in the latest quarter, The investment management firm added 2,807 additional shares and now holds a total of 100,132 shares of Dolby Laboratories which is valued at $5,002,595. Dolby Laboratories makes up approx 0.01% of American Century Companies Inc’s portfolio.Newsquare Capital reduced its stake in DLB by selling 22 shares or 6.08% in the most recent quarter. The Hedge Fund company now holds 340 shares of DLB which is valued at $16,986. Acadian Asset Management added DLB to its portfolio by purchasing 232 company shares during the most recent quarter which is valued at $11,449.

Dolby Laboratories opened for trading at $49.76 and hit $50.55 on the upside on Friday, eventually ending the session at $50.31, with a gain of 0.76% or 0.38 points. The heightened volatility saw the trading volume jump to 4,65,819 shares. Company has a market cap of $5,044 M.

On the company’s financial health, Dolby Laboratories reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.66. The company had revenue of $277.60 million for the quarter, compared to analysts expectations of $268.04 million. The company’s revenue was up 19.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 EPS.

Many Wall Street Analysts have commented on Dolby Laboratories. Company shares were Reiterated by Dougherty & Company on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 57 from a previous price target of $54 .Company shares were Reiterated by Dougherty & Company on Apr 28, 2016 to “Buy”, Firm has raised the Price Target to $ 54 from a previous price target of $46 .

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.